Growth & Scale CTS operates as a nonprofit blood and plasma testing lab with 500-1000 employees and revenue in the 100M-250M range, presenting a mid-market opportunity for enhanced lab management, workflow optimization, and enterprise software partnerships.

Geographic Footprint With seven facilities across Charlotte, Dallas, Memphis, Phoenix, St. Louis, San Marcos, and Tampa, CTS offers multiple regional accounts and potential for centralized data integration, supply chain efficiency, and cross-site QA standardization initiatives.

Regulatory Focus The organization tests for all FDA-required infectious disease markers and screening tests, indicating a need for compliant data reporting, secure data exchange, and robust quality systems to support stringent regulatory frameworks.

Leadership Momentum Appointment of a new Chief Operating Officer in January 2026 signals strategic operations enhancements, presenting a window for process optimization services, project management office support, and technology modernization efforts.

Technology & Partners Current tech stack includes Zoho, Office 365, Google Analytics, and custom C# solutions, suggesting opportunities for integrated cloud workflows, analytics-driven reporting, cybersecurity hardening, and vendor consolidation or modernization projects.